|Bid||4.1400 x 800|
|Ask||4.2200 x 1400|
|Day's Range||4.1573 - 4.3200|
|52 Week Range||3.9600 - 18.4500|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Even the best investor on earth makes unsuccessful investments. But it should be a priority to avoid stomach churning...
Is Neuronetics, Inc. (NASDAQ:STIM) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among hedge fund investors have historically outperformed the market after adjusting […]
Neuronetics (STIM) delivered earnings and revenue surprises of 9.76% and -0.78%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...
Neuronetics (STIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Neuronetics (STIM) delivered earnings and revenue surprises of 9.30% and 4.89%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
JNJ earnings report could be a boon for medical stocks Boston Scientific and Penumbra, an analyst said Wednesday. Boston has efforts in electrophysiology. Penumbra works in stroke treatment.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 2) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) ...
Even the best stock pickers will make plenty of bad investments. And unfortunately for Neuronetics, Inc. (NASDAQ:STIM...
Fairfield, CT, based Investment company General Electric Co buys Westinghouse Air Brake Technologies Corp, Neuronetics Inc during the 3-months ended 2019Q1, according to the most recent filings of the ...
On a per-share basis, the Malvern, Pennsylvania-based company said it had a loss of 42 cents. The medical device company focused on psychiatric disorders posted revenue of $12.7 million in the period. ...
While small-cap stocks, such as Neuronetics, Inc. (NASDAQ:STIM) with its market cap of US$282m, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a dow...